1 Min Read
March 6 (Reuters) - Recro Pharma Inc
* Recro Pharma reports year end 2016 financial results
* Sees FY 2017 revenue $55 million to $60 million Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.